CD200 Molecule (CD200) Kits ELISA

glycoprotein\; involved in neuronal cell-to-cell interaction [RGD, Feb 2006].. De plus, nous expédions CD200 Anticorps (214) et CD200 Protéines (37) et beaucoup plus de produits pour cette protéine.

list all ELISA KIts Gène GeneID UniProt
CD200 4345 P41217
CD200 24560  
CD200 17470  
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne

Top CD200 Kits ELISA sur

Showing 10 out of 20 products:

Catalogue No. Reactivité Sensibilité Gamme Images Quantité Livraison Prix Détails
Humain 12.9 pg/mL 31.2 pg/mL - 2000 pg/mL 96 Tests 13 to 16 Days
Rat 11.75 pg/mL 47-3000 pg/mL Typical standard curve 96 Tests 15 to 18 Days
Souris 0.078 ng/mL 0.312-20 ng/mL   96 Tests 15 to 18 Days
Humain 2 pg/mL n/a   96 Tests 11 to 16 Days
  96 Tests 15 to 18 Days
  96 Tests 15 to 18 Days
  96 Tests 15 to 18 Days
Boeuf (Vache)
  96 Tests 15 to 18 Days
  96 Tests 15 to 18 Days
  96 Tests 15 to 18 Days

CD200 Kits ELISA mieux référencés

  1. Human CD200 Kit ELISA pour Sandwich ELISA - ABIN417537 : Kacerovsky, Drahosova, Krejsek, Musilova, Hornychova, Matula, Simetka, Jacobsson, Andrys: Amniotic fluid CD200 levels in pregnancies complicated by preterm prelabor rupture of the membranes. dans The journal of maternal-fetal & neonatal medicine 2013 (PubMed)

Plus Kits ELISA pour CD200 partenaires d'interaction

Human CD200 Molecule (CD200) interaction partners

  1. this paper describes trophoblast CD200 expression in successful human pregnancies and missed abortions

  2. this study shows that soluble CD200 in secretory phase endometriosis endometrial venules may explain endometriosis pathophysiology and provide a novel treatment target

  3. the single nucleotide polymorphism rs3746444 in miR499a could affect the prognosis of nonsmall cell lung carcinoma patients by regulating the expression of CD200.

  4. Results suggest that CD200 antigen (CD200)-positive cancer associated fibroblasts (CAFs) can augment the sensitivity to EGFR-tyrosine kinase inhibitor (EGFR-TKI), gefitinib and may possess far reaching applications in the therapeutic use of EGFR-TKIs.

  5. CD200 expression can also be of prognostic and therapeutic value in CLL cases.

  6. Introduction of a siRNA for one of these TFs, POTEA, reversed CD200C-tail regulation of altered cell proliferation

  7. This is the first study to show that CD200 expression in mantle cell lymphoma, though uncommon, identifies a subgroup of mantle cell lymphoma patients with characteristic pathological features, frequent non-nodal leukemic variant, and an indolent clinical course.

  8. Both pancreatic solid pseudopapillary neoplasms and neuroendocrine tumors expression CD200.

  9. CD200 is highly expressed in the placenta amniotic membrane-derived mesenchymal stem cells under hypoxic conditions.

  10. overexpression of human CD200 in donor pigs could constitute a promising strategy for overcoming xenograft rejection.

  11. Our results support the fact that CD200 can be added to routine Chronic lymphoproliferative disorders panel as it is useful in subcategorizing them. However, inclusion of CD20 ABC to routine panel does not seem plausible but may be done for difficult diagnostic cases or where anti-CD20 therapy is planned.

  12. A diligent morphological examination to look for the presence of hairy cells along with flow cytometric immunophenotyping showing consistent bright expression of CD200, in addition to well-described characteristic immunophenotype, helps in correctly diagnosing the case. This can be further confirmed by the consistent presence of V600E point mutation in BRAF gene.

  13. CD200(+) and/or CD56(+) positive expression in B-ALL patients at diagnosis is a poor prognostic biomarker.

  14. CD200 was expressed in 97.3% of atypical chronic lymphocytic leukemia cases, whereas it was dimly expressed in only 6.1% of mantle cell lymphoma cases.

  15. CD200 and/or CD56 positive expression in B-ALL at diagnosis suggest a poor prognosis and may be associated with biological aggressiveness.

  16. downregulation of CD200 expression resulted in an imbalance of increased Th1 cytokine and decreased Th2 cytokine production in placental trophoblasts in preeclampsia

  17. This is the first report of CD200 mRNA and protein expression in patients with transitional cell carcinoma of the human bladder. TCC tissues showed significantly higher CD200 expression than normal bladder tissues. CD200 signals were also higher in metastasized compared to localized TCC. The data provide a strong indication for a putative role of CD200 in the immune-evasion of bladder cancer.

  18. Our data confirm a negative impact of ABCG2 and CD200 overexpression also in AML patients considered at favorable risk according to ELN cytogenetic/molecular classification.

  19. Residual CD200 activity may prevent completion of abortions via induction of Treg cells. In chronic histiocytic intervillositis, infiltrating maternal effector T cells may block Treg induction. An autocrine role for CD200-CD200R interaction versus inhibition of soluble CD200 by soluble CD200R is discussed.

  20. patients with Autosomal dominant polycystic kidney disease have activated soluble CD200 levels which were related to renal function and inflammation.

Mouse (Murine) CD200 Molecule (CD200) interaction partners

  1. blockade of the endogenous ligand CD200 prevented the tumorigenic effect of CD200R-expressing myeloid cells in the tumor microenvironment, whereas agonistic anti-CD200R has no effect on tumor development

  2. CD200 plays a central role in regulating the inflammatory responses and the anti-bacterial activity of macrophages, at least partially, through suppressing p38 activity.

  3. Results demonstrated that loss of CD200 was caused by neuronal death and was one of contributing factors in microglial activation after cerebral ischemia. ICV injection of rCD200 protein could suppress activation of microglia in vivo.

  4. Foxp3 is essential for beneficial outcome of the microglial response and depends upon signalling by the immunoglobulin CD200 through its receptor (CD200R)

  5. our murine studies suggest that the coinhibitory molecule CD200 does not appear to play a prominent role in the early onset of COPD-like features

  6. CD200 expression by tumor or host cells is important to regulation of immunotherapy in a mouse breast cancer model.

  7. Following spinal cord injury, newly formed endothelial cells express CD200 ligand at time points critical for repair.

  8. The CD200:CD200R axis plays an immunoregulatory role in control of DSS induced colitis in mice

  9. Data show that neutrophil infiltration of tissues was markedly decreased in CD200 antigen (tg) transgenic animals and increased in CD200 receptor 1 CD200R1(-/-) knockout mice.

  10. we show a causal role for the CD200-CD200R inhibitory axis in arteriogenesis in a murine hindlimb ischemia model.

  11. CD200 upregulation in reactive glial cells is modulated through PPAR-gamma.

  12. [review] Several bacterial strains can bind to mouse paired Ig-like receptors (PIRs) receptor to suppress macrophage proinflammatory responses.

  13. Anti-CD200R2, anti-IL-9, anti-IL-35, or anti-TGF-beta abolishes increased graft survival and Treg induction induced in cromolyn-treated CD200R1KO.CD200tg mice, and suggest combined role of mast cells and Tregs.

  14. a role for both graft and host CD200/CD200R expression in increased allograft survival.

  15. The main sites of CD200/CD200 receptor (CD200R) interaction in neonates and blood vessels, until adulthood, highlight the possible role of the CD200/CD200R system in microglial development and renewal.

  16. CD200 may be expressed in the alternative activation of microglia and play a beneficial role in neuroinflammation.

  17. Findings suggest sCD200 as a novel prognostic marker and therapeutic target for chronic lymphocytic leukemia (CLL).

  18. a local (to the grafted tissue) tolerance mechanism initiated after CD200/CD200R engagement in primary graft recipients can lead to prolonged survival of grafts on transfer to secondary control nontransgenic recipients.

  19. the increased CD200 expression by breast cancer cells (and/or host tissue) may be an important variable involved in determining the risk of metastasis.

  20. It was demonstrated for the first time that the absence of CD200R signaling inhibits outgrowth of an endogenous skin tumor irrespective of CD200 expression by the tumor cells.

CD200 profil antigène

Antigen Summary

glycoprotein\; involved in neuronal cell-to-cell interaction

Gene names and symbols associated with CD200 Molecule (CD200) Kits ELISA

  • CD200 molecule (CD200) anticorps
  • Cd200 molecule (Cd200) anticorps
  • CD200 antigen (Cd200) anticorps
  • CD200 molecule (Cd200) anticorps
  • CD200 anticorps
  • Cspmo2 anticorps
  • DKFZp459C0716 anticorps
  • MOX1 anticorps
  • Mox2 anticorps
  • MRC anticorps
  • MRCOX2 anticorps
  • OX-2 anticorps
  • OX2 anticorps

Protein level used designations for CD200 Molecule (CD200) Kits ELISA

CD200 antigen , MRC OX-2 antigen , OX-2 membrane glycoprotein , antigen identified by monoclonal antibody MRC OX-2 , CD200 molecule , Cd200 antigen , cell surface protein (thymocyte antigen identified by monoclonal antibody MRC-OX2)

4345 Homo sapiens
460583 Pan troglodytes
24560 Rattus norvegicus
534910 Bos taurus
418425 Gallus gallus
607499 Canis lupus familiaris
708110 Macaca mulatta
100172623 Pongo abelii
17470 Mus musculus
100734157 Cavia porcellus
100626182 Sus scrofa
Fournisseurs de qualité sélectionnés pour CD200 (CD200) Kits ELISA
Avez-vous cherché autre chose?